Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cardiac biomarkers market reached a value of US$ 9.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 14.9 Billion by 2027, exhibiting at a CAGR of 8.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

Global Cardiac Biomarkers Market Drivers:

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac biomarkers market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on type, location of testing, and application.

Breakup by Type:

  • Troponins (T and I) 
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP 
  • Ischemia Modified Albumin (IMA) 
  • Others
     

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.

Breakup by Location of Testing:

  • Laboratory Testing 
  • Point of Care Testing
     

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Breakup by Application:

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
     

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Regional Insights:

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America
     

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Location of Testing, Application, Region
Region Covered North America, Asia Pacific, Europe, Latin America, Middle East and Africa
Companies Covered Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License $ 2499
Five User License $ 3499
Corporate License $ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Cardiac Biomarkers Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Type
    5.5    Market Breakup by Location of Testing
    5.6    Market Breakup by Application
    5.7    Market Breakup by Region
    5.8    Market Forecast
6   Market Breakup by Type
    6.1    Troponins (T and I) 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Myocardial Muscle Creatine Kinase (CK-MB) 
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Myoglobin 
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Brain Natriuretic Peptide (BNPs) or NT-proBNP 
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Ischemia Modified Albumin (IMA) 
        6.5.1    Market Trends
        6.5.2    Market Forecast
    6.6    Others 
        6.6.1    Market Trends
        6.6.2    Market Forecast
7   Market Breakup by Location of Testing 
    7.1    Laboratory Testing
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Point of Care Testing
        7.2.1    Market Trends
        7.2.2    Market Forecast
8   Market Breakup by Application
    8.1    Myocardial Infarction
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Congestive Heart Failure
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Acute Coronary Syndrome
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Atherosclerosis
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Others
        8.5.1    Market Trends
        8.5.2    Market Forecast
9   Market Breakup by Region
    9.1    North America 
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Asia Pacific 
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Europe
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa 
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America 
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  Global Cardiac Biomarkers Industry: SWOT Analysis 
    10.1    Overview 
    10.2    Strengths
    10.3    Weaknesses 
    10.4    Opportunities
    10.5    Threats
11  Global Cardiac Biomarkers Industry: Value Chain Analysis 
12  Global Cardiac Biomarkers Industry: Porters Five Forces Analysis 

    12.1     Overview 
    12.2     Bargaining Power of Buyers
    12.3     Bargaining Power of Suppliers 
    12.4     Degree of Competition
    12.5     Threat of New Entrants
    12.6     Threat of Substitutes
13  Global Cardiac Biomarkers Industry: Price Analysis 
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories    
        14.3.2    Alere Inc. 
        14.3.3    Beckman Coulter  
        14.3.4    Becton, Dickinson And Co. 
        14.3.5    Biomerieux 
        14.3.6    Bio-Rad Laboratories 
        14.3.7    Randox Laboratories
        14.3.8    Roche Diagnostics Corporation 
        14.3.9    Siemens Healthcare 
        14.3.10   Thermo Fisher Scientific


List of Figures

Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2021
Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2021
Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2021
Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2021
Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
Figure 10: Global: Cardiac Biomarkers Industry: Porter’s Five Forces Analysis
Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027


List of Tables

Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2022-2027
Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Cardiac Biomarkers Market Structure
Table 7: Global: Cardiac Biomarkers Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global cardiac biomarkers market was valued at US$ 9.0 Billion in 2021.

We expect the global cardiac biomarkers market to exhibit a CAGR of 8.5% during 2022-2027.

The rising number of patients suffering from ACS due to shifting dietary patterns, coupled with the
increasing consumer awareness towards early diagnosis and treatment of cardiovascular diseases, is
currently driving the global cardiac biomarkers market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of several elective
surgeries pertaining to cardiac diseases to mitigate the risk of coronavirus infection upon hospital
visits.

Based on the location of testing, the global cardiac biomarkers market has been classified into
laboratory testing and point of care testing. Currently, laboratory testing holds largest market share.

Based on the application, the global cardiac biomarkers market can be bifurcated into myocardial
infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Among
these, myocardial infarction accounts for the majority of the total market share.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global cardiac biomarkers market include Abbott Laboratories,
Alere Inc., Beckman Coulter, Becton, Dickinson and Co., Biomerieux, Bio-Rad Laboratories, Randox
Laboratories, Roche Diagnostics Corporation, Siemens Healthcare, and Thermo Fisher Scientific.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links